🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 Master Structural Biology with BIOC669! 🚀 Register now! BIOC669 offers hands-on experience in macromolecular crystallography and cryoEM with a focus on solving and refining protein structures!

Now online in Cancer Discovery: Tumor-intrinsic Kinome Landscape of #PancreaticCancer Reveals New Therapeutic Approaches - by Yi Xu, Xianlu Laura Peng, Yeh Lab, and colleagues doi.org/10.1158/2159-8… UNC Pharmacology UNC Lineberger

💡 Unlock the Power of Structural Biology with BIOC669! 💡 Are you performing structural biology research or looking to enhance your ability to work with protein structures? BIOC669 is for you! Learn to handle your own data, refine structures, and apply best practices!

🌟 Build and Analyze Protein Structures with Confidence! 🌟 Register for BIOC669! Gain expertise in solving, building, and refining structures using your own or published data, while focusing on best practices and gold-standard metrics for high-quality results!

First author Amy Pomeroy presents her recently published work in Blood Cancer Discovery: A model of curative combination therapy for lymphoma by @amyEpomeroy and Adam C Palmer. Read the article: brnw.ch/21wRb8A

Researchers used our CMCF beamline to explore the power of proteins to stop cancer cells in their tracks. Read more: bit.ly/4fZ4WAA University of Toronto Chemistry at UofT Department of Molecular Genetics, U of T Sinai Health UNC-Chapel Hill UNC Lineberger UNC Pharmacology #cancer #cancerresearch #science

Join us for today's exciting seminar featuring Dr. Terry Kenakin, a distinguished member of our own department. Come and hear Dr. Kenakin speak on his groundbreaking research on drug-receptor interactions and the molecular pharmacology of receptors!

With an illustrious career that spans from early work with Nobel Laureate James Black to pivotal contributions at GSK and UNC, Dr. Kenakin's discoveries have revolutionized our understanding of drug action and led to novel treatments for diseases like AIDS. Join us today at 4pm!

Meet Dr. Brian Krumm, a scientist advancing GPCR research. He uncovered the first crystal structure of the active-state kappa opioid receptor with a state-distinct nanobody. Join us today to hear what he’s accomplished since!

In Roth Lab Bryan Roth, Dr. Brian Krumm contributed to revealing the crystal structure of the serotonin 5-HT2A GPCR and advanced Cryo-EM studies of GPCRs interacting with their cognate G-proteins. Join us today to discover how this work deepens our understanding of receptors!

🚨 We're excited to share that Dr. Zoe McElligott was recently featured in a WRAL news segment discussing the rise of THC-infused beverages, during which she shared insights on the psychoactive effects of these drinks. Check out the full segment: tinyurl.com/n2sewfjd

New paper by Dr. Amy Pomeroy! A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma Out now in Blood Cancer Discovery Blood Cancer Discovery doi.org/10.1158/2643-3… #mathonc #lymsm #BloodCancer 1/n

Congrats to Drs. Amy Pomeroy Dr. Amy Pomeroy and Adam Palmer Adam C Palmer! They published a mathematical model on multi-drug therapy with clinical implications that address tumor and patient heterogeneity in drug sensitivity! Read more through Blood Cancer Discovery: aacrjournals.org/bloodcancerdis…

“I allow the science to lead the way,” said Dr. Kizzmekia Corbett-Helaire KizzyPhD at the 2024 AAMC Annual Meeting. We proudly invite this trailblazer and UNC alumna to headline the Curtis Harper Distinguished Lectureship. Don’t miss her insight on discovery beyond boundaries!

We honor Dr. Curtis Harper, the first African American tenured faculty UNC Pharmacology and pioneering toxicologist. His legacy inspires the Harper Lectureship. This year, we welcome Dr. Kizzmekia Corbett-Helaire KizzyPhD, a trailblazer continuing Harper’s commitment to excellence.

A vaccine visionary and STEM advocate, Dr. Kizzmekia Corbett-Helaire KizzyPhD — who helped develop mRNA-1273 just 66 days after SARS-CoV-2’s sequence release — will deliver the keynote at the 5th Annual Curtis Harper Lectureship. Please join us in honoring innovation!